Differential alterations in basal and D-amphetamine-induced behavioural pattern following 6-OHDA or ibotenic acid lesions into the dorsal striatum

Behavioural Brain Research

Volumn 97, Issue 1-2, 1998, Pages 13-28

  Antoniou, Katerina ^a   Papadopoulou Daifotis, Zetta ^b   Kafetzopoulos, Evangelos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

6 OHDA; Behavioural pattern; D Amphetamine; Dorsal striatum; Ibotenic acid; Rat

Indexed keywords

DEXAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; HUNTINGTON CHOREA; LOCOMOTION; MALE; MOTOR ACTIVITY; NERVE PROJECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; EXCITATORY AMINO ACID AGONISTS; GROOMING; IBOTENIC ACID; INJECTIONS; MALE; MOTOR ACTIVITY; NEOSTRIATUM; OXIDOPAMINE; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS; YAWNING;

EID: 0032404044     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(98)00014-X     Document Type: Article

References (61)

1. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioural recovery from brain injury. J Neurochem. 48:1987;390-399.
2. Amalric M., Koob G.F. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J Neurosci. 7:1987;2129-2134.
3. Amalric M., Ouagazzal A., Baunez C., Nieoullon A. Functional interactions between glutamate and dopamine in the rat striatum. Neurochem Int. 25:1994;123-131.
4. Antoniou K., Kafetzopoulos E. A comparative study of the behavioural effects of D-amphetamine and apomorphine in the rat. Pharmacol Biochem Behav. 39:1991;61-70.
5. Antoniou K., Kafetzopoulos E. Behavioural effects of amphetamine and apomorphine after striatal lesions in the rat. Pharmacol Biochem Behav. 43:1992;705-722.
6. Antoniou K., Kafetzopoulos E. The pattern of locomotor activity after cocaine treatment in the rat. Behav Pharmacol. 7:1996;237-244.
7. Apicella P., Legallet E., Nieoullon A., Trouche E. Quantitative behavioural study of the acute and long-term effects of two-stage bilateral 6-OHDA-induced lesions of the nigrostriatal dopaminergic system in monkeys. Behav Neurosci. 2:1995;329-341.
8. Breese G.R., Taylor T.D. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurones. J Pharmacol Exp Ther. 174:1970;413-420.
9. Breese G.R., Taylor T.D. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br J Pharmacol. 42:1971;88-99.
10. Brook C., Iversen S. Changed eating and locomotor activity behaviour in the rat after 6-hydroxydopamine lesions to the substantia nigra. Neuropharmacology. 14:1975;95-105.
11. Cadet J.L., Last R., Kostic V., Przedborski S., Jackson-Lewis V. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Pharmacol Biochem Behav. 26:1991;707-713.
12. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19:1996;19-24.
13. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology. 6th:1991;Oxford University Press, Oxford.
14. Costall B., Naylor R.J. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Eur J Pharmacol. 40:1976;9-19.
15. Costall B., Naylor R.J. Behavioural aspects of dopamine agonists and antagonists. Horn A.S., Korf J., Westerink B.H.C. The Neurobiology of Dopamine. 1979;555-576 Academic Press, London.
16. Cousins M.S., Salamone J.D. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioural investigation. Neuroscience. 70:1996;849-859.
17. Creese I., Iversen S.D. Amphetamine response in rat after dopamine neuron destruction. Nature. 238:1972;247-248.
18. Creese I., Iversen S.D. The role of forebrain dopamine system in amphetamine-induced stereotyped behaviour in the rat. Psychopharmacology. 39:1974;345-357.
19. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13:1990;286-289.
20. Di Giulio A.M., Groppetti A., Cattabeni F., Galli C.L., Maggi A., Algeri S., Ponzio F. Significance of dopamine metabolites in the evaluation of drugs acting on dopamine neurons. Eur J Pharmacol. 52:1978;201-207.
21. Dunnett. S.B., Iversen S.D. Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum. Brain Res. 248:1982;121-127.
22. Fink J.S., Smith G.P. Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of the anteromedial caudate. Pharmacol Biochem Behav. 11:1979;23-30.
23. Fink J.S., Smith G.P. Relationships between selective denervation of dopamine terminal fields in the anterior forebrain and behavioural responses to amphetamine and apomorphine. Brain Res. 201:1980;107-127.
24. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
25. Glick S., Marsanico R. Shifting of the D-amphetamine dose-response curve in rats with frontal cortical ablations. Psychopharmacology. 36:1974;109-115.
26. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
27. Ichitani Y., Okamura H., Matsumoto Y., Nagatsu T., Ibata Y. Degeneration of nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res. 549:1991;350-353.
28. Iversen S.D., Koob G.F. Behavioural implications of dopaminergic neurons in the mesolimbic system. Adv Biochem Psychopharmacol. 16:1977;209-214.
29. Iversen S.D., Dunnett S.B. Functional organization of striatum as studied with neural grafts. Neuropsychologia. 28:1990;601-626.
30. Joyce E.M., Iversen S.D. Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition. Psychopharmacology. 83:1984;363-366.
31. Keefe K.A., Salamone J.D., Zigmond M.J., Stricker E.M. Paradoxical kinesia in Parkinsonism is not caused by dopamine release. Arch Neurol. 46:1989;1070-10759.
32. Kelley A.E., Lang C.G., Gauthier A.M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology. 95:1988;556-559.
33. Kelley A.E., Gauthier A.M., Lang C.G. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behaviour. Behav Brain Res. 35:1989;27-39.
34. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol. 40:1976;45-56.
35. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
36. Kokkinidis L., Kirkby R.D. Alterations in amphetamine-induced locomotor activity and stereotypy after electrical stimulation of the nucleus accumbens and neostriatum. Life Sci. 44:1989;633-664.
37. Marshall J.F., O'Dell S.J., Navarette R., Rosenstein A.J. Dopamine high affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience. 37:1990;11-21.
38. Marshall J.F. Neural plasticity and recovery of function after brain injury. Int Rev Neurobiol. 26:1985;201-247.
39. Marshall J.F., Richardson S.R., Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J Comp Physiol Psychol. 87:1974;808-830.
40. Mason S.T., Fibiger H.C. Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea. Brain Res. 155:1978;313-329.
41. Mason S.T., Sanberg P.R., Fibiger H.C. Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotypy: similarities to Huntington's chorea. Science. 201:1978;352-355.
42. Onn S.P., Berger T.W., Stricker E.M., Zigmond J.M. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res. 376:1986;8-19.
43. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 13:1990;254-258.
44. Papadopoulou-Daifotis Z., Antoniou K., Vamvakidis A., Kalliteraki I., Varonos D.D. Neurochemical changes in dopamine and serotonin turnover rate in discrete regions of rat brain after the administration of glycinergic compounds. Acta Therapeut. 21:1995;5-18.
45. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, London.
46. Pijnenburg A.J.J., Honig W.M.M., Van Rossum J.M. Inhibition of D-amphetamine-induced locomotor activity by injection of haloperidol into nucleus accumbens of the rat. Psychopharmacology. 41:1975;87-95.
47. Pisa M. Motor somatotopy in the striatum of rat: manipulation, biting and gait. Behav Brain Res. 27:1987;21-35.
48. Riederer P., Lange K.W., Kornhuber J., Jellinger K. Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis. J Neural Transmitt. 34:1991;203-210.
49. Robinson T.E., Castaneda E., Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can J Psychol. 44:1990;253-275.
50. Robinson T.E., Moscary Z., Camp D.M., Whishaw Q. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci. 14:1994;2687-2696.
51. Sakai K., Gash D.M. Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat. Brain Res. 633:1994;144-150.
52. Schmidt W.J., Bubser M., Hauber W. Behavioural pharmacology of glutamate in the basal ganglia. J Neural Transmitt. 38:1992;65-89.
53. Sharp T., Zetterstrom T., Series H.G., Carlsson A., Grahame-Smith D.G., Ungerstedt U. HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life Sci. 41:1987;869-872.
54. 3H]leucine and horseradish peroxidase. Brain Res. 167:1979;139-155.
55. Spruijt B.M., Gispen W.H. Behavioural sequencies as an easily quantifiable parameter in experimental studies. Physiol Behav. 6:1984;151-156.
56. Stathis P., Antoniou K., Papadopoulou-Daifotis Z., Rimikis M., Varonos D.D. Risperidone: a novel antipsychotic with many atypical properties? Psychopharmacology. 127:1996;181-186.
57. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand. 367:1971;69-93.
58. Venero J.L., Romero-Ramos M., Revuelta M., Machado A., Cano J. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system. Brain Res. 672:1995;153-158.
59. White N.M. A functional hypothesis concerning the striatal matrix and patches: mediation of S-R memory and reward. Life Sci. 45:1989;1943-1957.
60. Winn P., Robbins T.W. Comparative effects of infusions of 6-Hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-Hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat. Neuropharmacology. 24:1985;25-31.
61. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neuron some clinical and basic implications. Trends Neurosci. 13:1990;290-296.